Pharmacologic therapy for behavioral symptoms of Alzheimer's disease

Clin Geriatr Med. 2001 May;17(2):359-76. doi: 10.1016/s0749-0690(05)70073-2.

Abstract

Behavioral signs and symptoms in dementia are common, morbid, classifiable, and treatable. The current state-of-the-art approach is to evaluate carefully for social or environmental causes, intercurrent medical conditions, or other triggers of the behavior and attempt to deal with those directly. When these conservative steps fail, there may be a role for medication. A rational approach typically hinges on matching the most dominant behavioral target symptoms to the most relevant medication class, the key information of which is summarized.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Alzheimer Disease / complications*
  • Depression / drug therapy
  • Depression / etiology
  • Geriatric Assessment
  • Humans
  • Mental Disorders / drug therapy*
  • Mental Disorders / etiology*
  • Patient Selection
  • Psychomotor Agitation / drug therapy
  • Psychomotor Agitation / etiology
  • Psychotropic Drugs / classification
  • Psychotropic Drugs / pharmacology
  • Psychotropic Drugs / therapeutic use*
  • Risk Factors
  • Sleep Wake Disorders / drug therapy
  • Sleep Wake Disorders / etiology

Substances

  • Psychotropic Drugs